abstract |
The invention relates generally to new hybrid cell lines, and in particular to hybrid cell lines for the production of monoclonal antibodies against an antigen which was found on activated human lymphocytes, the interleukin-2 receptor, the antibodies produced therewith, and therapeutic and diagnostic methods and preparations under Use of the antibodies. |